If one thing to learn from SUV, it is that markets can alter the value of one's investment very quickly and often adversely and perhaps another is to perhaps take a longer term view and hope that the adversity changes. SUV may yet be a turnaround story in time - just how much a turnaround and how much more time is yet unknown. The more the sales, the more the income, the more chance of a quicker recovery. Bring it on.
Ann: Sales Agreement Executed in High-value Pharmaceutical market, page-9
Add SUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $56.04M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 6.0¢ | 5.6¢ | $212.4K | 3.694M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 547241 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 423730 | 1 |
View Market Depth
| Last trade - 14.37pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.8¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 5.7¢ | 6.0¢ | 5.7¢ | 737848 | ||
| Last updated 15.08pm 29/05/2024 ? | |||||
| SUV (ASX) Chart |